Experimental MS Pill Continues to Show Promise
Linkedin

Experimental MS Pill Continues to Show Promise

New York City : NY : USA | Sep 19, 2012 at 2:19 PM PDT
Source: WebMD
XX XX
Views: Pending
 
In two late-phase studies appearing in The New England Journal of Medicine , the drug BG-12 (dimethyl fumarate) reduced relapses by about half in patients with the most common form of MS. If approved by the FDA, BG-12, which is being developed by drug maker Biogen Idec, will become the third oral drug... FULL ARTICLE AT WebMD
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.